{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:10:25Z","timestamp":1739999425253,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07714-8","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:34:52Z","timestamp":1739997292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ceruloplasmin administration in the preclinical mouse model of aceruloplasminemia reveals a sex-related variation in biodistribution"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-3932","authenticated-orcid":false,"given":"Sara","family":"Belloli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Monterisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-8797","authenticated-orcid":false,"given":"Paolo","family":"Rainone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-0016","authenticated-orcid":false,"given":"Angela","family":"Coliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Zanardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3957-0719","authenticated-orcid":false,"given":"Andrea","family":"Caricasole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria","family":"Moresco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-3472","authenticated-orcid":false,"given":"Massimo","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"7714_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","volume":"22","author":"N. E Hellman","year":"2002","unstructured":"Hellman, N. E. & Gitlin, J. D. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22, 439\u2013458 (2002).","journal-title":"Annu. Rev. Nutr."},{"key":"7714_CR2","doi-asserted-by":"publisher","first-page":"e80274","DOI":"10.1371\/journal.pone.0080274","volume":"9","author":"E Arner","year":"2014","unstructured":"Arner, E. et al. Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS ONE9, e80274 (2014).","journal-title":"PLoS ONE"},{"key":"7714_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3390\/ijms24021150","volume":"24","author":"S Raia","year":"2023","unstructured":"Raia, S. et al. Ceruloplasmin-deficient mice show dysregulation of lipid metabolism in liver and adipose tissue reduced by a protein replacement. Int. J. Mol. Sci. 24, 1150 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"7714_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11011-009-9169-y","volume":"24","author":"T. A Rouault","year":"2009","unstructured":"Rouault, T. A., Zhang, D. L. & Jeong, S. Y. Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab. Brain Dis. 24, 673\u2013684 (2009).","journal-title":"Metab. Brain Dis."},{"key":"7714_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1172\/JCI118768","volume":"98","author":"L. W Klomp","year":"1996","unstructured":"Klomp, L. W., Farhangrazi, Z. S., Dugan, L. L. & Gitlin, J. D. Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Investig. 98, 207\u2013215 (1996).","journal-title":"J. Clin. Investig."},{"key":"7714_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3389\/fnins.2018.00903","volume":"12","author":"A Piperno","year":"2018","unstructured":"Piperno, A. & Alessio, M. Aceruloplasminemia: waiting for an efficient therapy. Front. Neurosci. 12, 903 (2018).","journal-title":"Front. Neurosci."},{"key":"7714_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10534-019-00189-1","volume":"32","author":"V. B Vasilyev","year":"2019","unstructured":"Vasilyev, V. B. Looking for a partner: ceruloplasmin in protein-protein interactions. Biometals 32, 195\u2013210 (2019).","journal-title":"Biometals"},{"key":"7714_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.bbadis.2010.07.011","volume":"1802","author":"S Kono","year":"2010","unstructured":"Kono, S. et al. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin. Biochim. Biophys. Acta 1802, 968\u2013975 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"7714_CR9","doi-asserted-by":"publisher","first-page":"27144","DOI":"10.1074\/jbc.M301988200","volume":"278","author":"S. Y Jeong","year":"2003","unstructured":"Jeong, S. Y. & David, S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 278, 27144\u201327148 (2003).","journal-title":"J. Biol. Chem."},{"key":"7714_CR10","doi-asserted-by":"publisher","first-page":"18568","DOI":"10.1523\/JNEUROSCI.3768-11.2011","volume":"31","author":"S Olivieri","year":"2011","unstructured":"Olivieri, S. et al. Ceruloplasmin oxidation, a feature of Parkinson\u2019s Disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. J. Neurosci. 31, 18568\u201318577 (2011).","journal-title":"J. Neurosci."},{"key":"7714_CR11","unstructured":"Miyajima, H. Aceruloplasminemia. in GeneReviews(R) (eds. Pagon, R. A. et al.) (Seattle, 1993)."},{"key":"7714_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01385-w","volume":"15","author":"L. H. P Vroegindeweij","year":"2020","unstructured":"Vroegindeweij, L. H. P., Boon, A. J. W., Wilson, J. H. P. & Langendonk, J. G. Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports. Orphanet. J. Rare Dis. 15, 105 (2020).","journal-title":"Orphanet. J. Rare Dis."},{"key":"7714_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnins.2019.00325","volume":"13","author":"G Marchi","year":"2019","unstructured":"Marchi, G., Busti, F., Lira Zidanes, A., Castagna, A. & Girelli, D. Aceruloplasminemia: a severe neurodegenerative disorder deserving an early diagnosis. Front. Neurosci. 13, 325 (2019).","journal-title":"Front. Neurosci."},{"key":"7714_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2018.02.036","volume":"51","author":"S Pelucchi","year":"2018","unstructured":"Pelucchi, S. et al. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia. Parkinsonism Relat. Disord. 51, 36\u201342 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"7714_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12876-020-01237-8","volume":"20","author":"M Ondrejkovi\u010dov\u00e1","year":"2020","unstructured":"Ondrejkovi\u010dov\u00e1, M. et al. New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson\u2019s disease. BMC Gastroenterol. 20, 95 (2020).","journal-title":"BMC Gastroenterol."},{"key":"7714_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/1873-3468.12978","volume":"592","author":"J Zheng","year":"2018","unstructured":"Zheng, J., Chen, M., Liu, G., Xu, E. & Chen, H. Ablation of hephaestin and ceruloplasmin results in iron accumulation in adipocytes and type 2 diabetes. FEBS Lett. 592, 394\u2013401 (2018).","journal-title":"FEBS Lett."},{"key":"7714_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/2211-5463.13740","volume":"14","author":"V Mannella","year":"2024","unstructured":"Mannella, V. et al. Lipid dysmetabolism in ceruloplasmin-deficient mice revealed both in vivo and ex vivo by MRI, MRS and NMR analyses. FEBS Open Biol. 14, 258\u2013275 (2024).","journal-title":"FEBS Open Biol."},{"key":"7714_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s42003-024-05820-7","volume":"7","author":"A Zanardi","year":"2024","unstructured":"Zanardi, A. et al. New orphan disease therapies from the proteome of industrial plasma processing waste- a treatment for aceruloplasminemia. Commun. Biol. 7, 140 (2024).","journal-title":"Commun. Biol."},{"key":"7714_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.15252\/emmm.201708361","volume":"10","author":"A Zanardi","year":"2018","unstructured":"Zanardi, A. et al. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia. EMBO Mol. Med. 10, 91\u2013106 (2018).","journal-title":"EMBO Mol. Med."},{"key":"7714_CR20","first-page":"23","volume":"57","author":"A Tridimas","year":"2021","unstructured":"Tridimas, A. et al. Three-year follow up of using combination therapy with fresh-frozen plasma and iron chelation in a patient with acaeruloplasminemia. JIMD Rep. 57, 23\u201328 (2021).","journal-title":"JIMD Rep."},{"key":"7714_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jtemb.2016.03.010","volume":"38","author":"P Dusek","year":"2016","unstructured":"Dusek, P., Schneider, S. A. & Aaseth, J. Iron chelation in the treatment of neurodegenerative diseases. J. Trace Elem. Med. Biol. 38, 81\u201392 (2016).","journal-title":"J. Trace Elem. Med. Biol."},{"key":"7714_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-12-410502-7.00007-7","volume":"110","author":"S Kono","year":"2013","unstructured":"Kono, S. Aceruloplasminemia: an update. Int. Rev. Neurobiol. 110, 125\u2013151 (2013).","journal-title":"Int. Rev. Neurobiol."},{"key":"7714_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1044-x","volume":"15","author":"S Belloli","year":"2018","unstructured":"Belloli, S. et al. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. J. Neuroinflamm. 15, 33 (2018).","journal-title":"J. Neuroinflamm."},{"key":"7714_CR24","doi-asserted-by":"publisher","DOI":"10.2310\/7290.2015.00007","volume":"14","author":"G Di Grigoli","year":"2015","unstructured":"Di Grigoli, G. et al. Radiosynthesis and preliminary biological evaluation of [18F]VC701, a radioligand for translocator protein. Mol. Imaging 14, 7290.2015.00007 (2015).","journal-title":"Mol. Imaging"},{"key":"7714_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.redox.2018.05.013","volume":"17","author":"M Chen","year":"2018","unstructured":"Chen, M. et al. Ceruloplasmin and hephaestin jointly protect the exocrine pancreas against oxidative damage by facilitating iron efflux. Redox Biol. 17, 432\u2013439 (2018).","journal-title":"Redox Biol."},{"key":"7714_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","volume":"396","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis, F. et al. Sex and gender: modifiers of health, disease, and medicine.  Lancet 396, 565\u2013582 (2020).","journal-title":"Lancet"},{"key":"7714_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/207504","volume":"2011","author":"O. P Soldin","year":"2011","unstructured":"Soldin, O. P., Chung, S. H. & Mattison, D. R. Sex differences in drug disposition. J. Biomed. Biotechnol. 2011, 1\u201314 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"7714_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmet.2017.01.006","volume":"25","author":"S Della Torre","year":"2017","unstructured":"Della Torre, S. & Maggi, A. Sex differences: a resultant of an evolutionary pressure? Cell Metab. 25, 499\u2013505 (2017).","journal-title":"Cell Metab."},{"key":"7714_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1515\/cclm-2012-0849","volume":"51","author":"G Baggio","year":"2013","unstructured":"Baggio, G., Corsini, A., Floreani, A., Giannini, S. & Zagonel, V. Gender medicine: a task for the third millennium. Clin. Chem. Lab. Med. 51, 713\u2013727 (2013).","journal-title":"Clin. Chem. Lab. Med."},{"key":"7714_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/biomedicines12020265","volume":"12","author":"S Allegra","year":"2024","unstructured":"Allegra, S., Chiara, F. & De Francia, S. Gender medicine and pharmacology. Biomedicines 12, 265 (2024).","journal-title":"Biomedicines"},{"key":"7714_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molmet.2018.02.012","volume":"15","author":"A Maggi","year":"2018","unstructured":"Maggi, A. & Della Torre, S. Sex, metabolism and health. Mol. Metab. 15, 3\u20137 (2018).","journal-title":"Mol. Metab."},{"key":"7714_CR32","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1021\/acs.molpharmaceut.1c00305","volume":"18","author":"G. S Clemente","year":"2021","unstructured":"Clemente, G. S. et al. [18 F]Atorvastatin pharmacokinetics and biodistribution in healthy female and male rats. Mol. Pharmaceutics 18, 3378\u20133386 (2021).","journal-title":"Mol. Pharmaceutics"},{"key":"7714_CR33","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s42003-022-04214-x","volume":"5","author":"V Murtaj","year":"2022","unstructured":"Murtaj, V. et al. Brain sex-dependent alterations after prolonged high fat diet exposure in mice. Commun. Biol. 5, 1276 (2022).","journal-title":"Commun. Biol."},{"key":"7714_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00925-8","volume":"12","author":"L Rischka","year":"2022","unstructured":"Rischka, L. et al. Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1. EJNMMI Res. 12, 53 (2022).","journal-title":"EJNMMI Res."},{"key":"7714_CR35","doi-asserted-by":"crossref","unstructured":"Sternlieb, I., Morell, A.G., Tucker, W.D., Greene, M.W. & Scheinberg, I.H. The incorporation of co into ceruloplasmin in vivo: studies with co and copper. 40, 1834\u20131840 (1961).","DOI":"10.1172\/JCI104407"},{"key":"7714_CR36","doi-asserted-by":"publisher","first-page":"e0149516","DOI":"10.1371\/journal.pone.0149516","volume":"11","author":"D Ramos","year":"2016","unstructured":"Ramos, D. et al. Mechanism of copper uptake from blood plasma ceruloplasmin by mammalian cells. PLoS ONE11, e0149516 (2016).","journal-title":"PLoS ONE"},{"key":"7714_CR37","doi-asserted-by":"publisher","first-page":"C140","DOI":"10.1152\/ajpcell.1990.258.1.C140","volume":"258","author":"S. S Percival","year":"1990","unstructured":"Percival, S. S. & Harris, E. D. Copper transport from ceruloplasmin: characterization of the cellular uptake mechanism. Am. J. Physiol. 258, C140\u2013C146 (1990).","journal-title":"Am. J. Physiol."},{"key":"7714_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/dme.12712","volume":"32","author":"L. H Vroegindeweij","year":"2015","unstructured":"Vroegindeweij, L. H. et al. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series. Diabet. Med. 32, 993\u20131000 (2015).","journal-title":"Diabet. Med."},{"key":"7714_CR39","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1074\/jbc.M112.418970","volume":"288","author":"A. L. P Chapman","year":"2013","unstructured":"Chapman, A. L. P. et al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J. Biol. Chem. 288, 6465\u20136477 (2013).","journal-title":"J. Biol. Chem."},{"key":"7714_CR40","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.rare.2023.100010","volume":"1","author":"I Ketata","year":"2023","unstructured":"Ketata, I. & Ellouz, E. New view of aceruloplasminemia: Systematic review and meta-analysis tracking dots from onset to disease development and iron-related features. Rare 1, 100010 (2023).","journal-title":"Rare"},{"key":"7714_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nchembio813","volume":"2","author":"S Shiva","year":"2006","unstructured":"Shiva, S. et al. Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat. Chem. Biol. 2, 486\u2013493 (2006).","journal-title":"Nat. Chem. Biol."},{"key":"7714_CR42","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/jnr.23349","volume":"92","author":"M. M Gresle","year":"2014","unstructured":"Gresle, M. M. et al. Ceruloplasmin gene-deficient mice with experimental autoimmune encephalomyelitis show attenuated early disease evolution. J. Neurosci. Res. 92, 732\u2013742 (2014).","journal-title":"J. Neurosci. Res."},{"key":"7714_CR43","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1523\/JNEUROSCI.22-15-06578.2002","volume":"22","author":"B. N Patel","year":"2002","unstructured":"Patel, B. N. et al. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578\u20136586 (2002).","journal-title":"J. Neurosci."},{"key":"7714_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07714-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07714-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07714-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:36:58Z","timestamp":1739997418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07714-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7714"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07714-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A.Ca. is employee of Kedrion S.p.A. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"264"}}